^
Association details:
Biomarker:No biomarker
Cancer:Cholangiocarcinoma
Drug:gemcitabine (DNA synthesis inhibitor) +
albumin-bound paclitaxel (Tubulin inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Primary Treatment for Unresectable and Metastatic Disease: Other Recommended Regimens...Gemcitabine + albumin-bound paclitaxel (cholangiocarcinoma only).